Overview

Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the Bioequivalence, assess food administration on the Pharmacokinetics with naloxegol.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Naloxegol